Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

CUSIP: 98422T100

Q4 2023 13F Holders as of 31 Dec 2023

Security identity
Shares outstanding
6,426,426
Holder snapshot
Share change
-909,000
Reported price per share
$0.55
Number of holders
33
Value change
-$1,543,598
Number of buys
12
Number of sells
7

Security key

98422T100

Report period

Q4 2023

Institutions

33

Top holders

10

Ownership snapshot

Top reported holders of XLO - Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Bain Capital Life Science...
13D/G signal
Evidence rows
15
Latest as of
30 Sep 2023
13F 3/4/5 Lead comparable stake: 44% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Bain Capital Life Sciences Investors, LLC
13F 3/4/5
Company · 10%+ Owner
44%
$5,919,421
2,805,413 shares
30 Sep 2023
Atlas Venture Life Science Advisors, LLC
13F
Company
13F
43%
$5,822,216
2,759,344 shares
30 Sep 2023
Octagon Capital Advisors LP
13F
Company
13F
36%
$4,892,035
2,318,500 shares
30 Sep 2023
FMR LLC
13F 3/4/5
Company · Other*
30%
$4,025,186
1,907,671 shares
30 Sep 2023
RiverVest Venture Management LLC
13F
Company
13F
22%
$3,041,447
1,441,444 shares
30 Sep 2023
Rock Springs Capital Management LP
13F 3/4/5
Company · 10%+ Owner
22%
$3,040,001
1,440,759 shares
30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
33
Shares
16,426,281
Rows available
33
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
30
Q4 2023 holders
33
Holder diff
3
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .